Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBT Margin (2023 - 2025)

Astera Labs' EBT Margin history spans 3 years, with the latest figure at 29.16% for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 2158.0% year-over-year to 29.16%, compared with a TTM value of 25.59% through Dec 2025, up 4622.0%, and an annual FY2025 reading of 25.59%, up 4622.0% over the prior year.
  • EBT Margin for Q4 2025 was 29.16% at Astera Labs, up from 29.0% in the prior quarter.
  • The five-year high for EBT Margin was 29.16% in Q4 2025, with the low at 150.24% in Q2 2023.
  • Average EBT Margin over 3 years is 21.82%, with a median of 4.68% recorded in 2024.
  • Year-over-year, EBT Margin crashed -2511bps in 2024 and then soared 13684bps in 2025.
  • Tracing ALAB's EBT Margin over 3 years: stood at 21.17% in 2023, then tumbled by -64bps to 7.58% in 2024, then skyrocketed by 285bps to 29.16% in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBT Margin are 29.16% (Q4 2025), 29.0% (Q3 2025), and 26.4% (Q2 2025).